Yahoo News Article Rating

Abortion is back at the Supreme Court. Here's what to know.

Mar 26, 2024 View Original Article
  • Bias Rating

    10% Center

  • Reliability

    75% ReliableGood

  • Policy Leaning

    10% Center

  • Politician Portrayal

    -4% Negative

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

11% Positive

  •   Liberal
  •   Conservative
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

68% : Misoprostol access is more difficult for anti-abortion activists to roll back because the drug is also used for a wide range of health issues, including the treatment of ulcers.
66% : Attorney Jessica Ellsworth will argue on behalf of Danco that the anti-abortion doctors bringing the case don't have standing to sue based on the idea that "some unspecified member [of the group] may be injured at some future time by the challenged action."
45% : The group of anti-abortion medical professionals formed in 2022 in Amarillo, Texas, the jurisdiction of the right-leaning U.S. District Court Judge Matthew Kascmaryk who ruled in 2023 to effectively ban mifepristone nationwide.
41% : But while a nationwide ban is not on directly on the table, the anti-abortion groups behind this case and allied conservative groups and elected officials have tried to prompt the court in briefings to consider even more sweeping restrictions -- including some, like full enforcement of the 150-year-old Comstock Act, that would function as de facto federal bans.
40% : Additionally, several groups submitting amicus briefs in the case point out that the studies the anti-abortion groups cited showing a purported surge in emergency room visits caused by mifepristone were retracted by the medical journal that published them after outside researchers flagged manipulation of the data and undisclosed conflicts of interest.
21% : The Biden administration, the makers of the drug, and abortion-rights advocates say those claims are too speculative to give the anti-abortion groups standing.
20% : Trump, who appointed three of the five justices who overturned Roe v. Wade, has floated a 16-week federal abortion ban and promised to find a compromise that would placate both abortion-rights and anti-abortion rights advocates.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link